Trending...
- House of Buneau Releases "Pretty Boy Heaven," A Cinematic Exploration of Beauty and Distance
- California and European Commission discuss cooperation to accelerate the global transition to a carbon-neutral, resilient, and equitable future
- High5VR Announces World's First Fully Immersive First-Person VR Movie
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Homology Medicines, Inc.. ("Homology" or "the Company") (NASDAQ: FIXX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Homology is the subject of a report published by Mariner Research on July 21, 2020. The report questions the efficacy of the Company's lead product candidate, HMI-102. The report alleges that the company concealed efficacy information and predicted that the drug would not continue to commercialization. Based on this report, shares of Homology dropped by more than 10% on July 24, 2020.
More on The Californer
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Homology is the subject of a report published by Mariner Research on July 21, 2020. The report questions the efficacy of the Company's lead product candidate, HMI-102. The report alleges that the company concealed efficacy information and predicted that the drug would not continue to commercialization. Based on this report, shares of Homology dropped by more than 10% on July 24, 2020.
More on The Californer
- California: Governor Newsom announces judicial appointments 3.27.2026
- Legal Powerhouses, Dance Drama, and Romance: Meet the New Platform Debuting This April
- Pet Furniture Meets Interior Design: Wooffy Redefines the Role of Dog Homes in Modern Living Spaces
- City to Add No-Cost Preschool to West Facilities Center in West Long Beach
- Snell & Wilmer Attorneys Emily Cheung and Kina Wong Appointed Co-Leads of CALA-OC Young Lawyers Cmte
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Filed Under: Business
0 Comments
Latest on The Californer
- LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
- California: Governor Newsom strengthens bans on insider betting by state officials, takes aim at corruption fueled by Trump
- GDE Tree Services Expands Operations into Sydney, NSW
- Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
- "Dave Simmons of StrataX Development: Why AB1033 and SB9 Are About to Rewrite California Real Estate"
- The Inner Power of Emotional Self-Leadership
- Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
- California: Governor Newsom signs legislation 3.26.26
- VBO Expands Event Manager 3.0 with Real-Time Sales Visibility, New Dashboards, and Operational Tools
- eBook Publishing Services in USA California Book Publishers Helps Authors Turn Ideas into Successful
- City of Long Beach to Host Recycle Your Bicycle Event on May 2
- Public Employees Are Asking: Are Our Pensions Secure?
- Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
- Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
- Drywall Repair Near Me Services Expand In Huntington Beach Orange County
- Mobile App Developers in California California Web Coders Builds High-Performance Apps for Modern Bu
- California Lutheran University Taps Pandemic Response Leader as Chief Strategy & Growth Officer
- For April Fools' Day: A poem about The Secret to Happiness! The secret is "Don't Say Nuthin'"
- Long Beach: Meredith Reynolds Appointed as Acting Director of Technology and Innovation Department
- California: Governor Newsom announces CHP crackdown: 12,600 arrests, 6,400 stolen cars recovered, 25 million deadly fentanyl doses seized in two years